Loading...
A145 “REAL WORLD” SAFETY AND EFFECTIVENESS OF VEDOLIZUMAB FOR ULCERATIVE COLITIS: RETROSPECTIVE STUDY FROM A TERTIARY CARE CANADIAN CENTRE
BACKGROUND: Vedolizumab (VDZ), a humanized monoclonal antibody which targets the α4β7 integrin and prevents homing of lymphocytes to the gut, was approved by Health Canada in 2015 for treatment of moderate to severe ulcerative colitis (UC). Its gut selective mode of action offers potential for a low...
Na minha lista:
| Udgivet i: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507784/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.146 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|